학술논문

Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
Document Type
Article
Source
In ESMO Open April 2022 7(2)
Subject
Language
ISSN
2059-7029